Sergio Duarte

7PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Computational physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 26, 2026
β-Catenin Signaling in Hepatocellular Carcinoma: Mechanisms of Therapeutic Resistance and Emerging Therapeutic Strategies.

|Aug 27, 2026
Independent Multi-Cohort RNA-Seq Analysis Does Not Support Recurrent DNAJB1::PRKACA Fusion in Hepatoblastoma or Biliary Atresia. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83.

|Aug 30, 2025
Recipient Versus Donor CYP3A4/5 Genotypes in Adult Liver Transplant Recipients to Achieve Therapeutic Tacrolimus Concentrations Early Post-Transplant.

Eda Eken, Sergio Duarte, Isabella Angeli-Pahim

|Jul 19, 2025
Understanding Immune Dynamics in Liver Transplant Through Mathematical Modeling.

Julia Bruner, Kyle Adams, Skylar Grey

|Jul 03, 2023
Personalized Tacrolimus Dosing After Liver Transplantation: A Randomized Clinical Trial.

Jeffrey Khong, Megan Lee, Curtis Warren

|Jan 21, 2023
Mechanisms of drug resistance in HCC.

Alexandra D Ladd, Sergio Duarte, Ilyas Sahin

Pageof 2

Frequent Collaborators

6 joint publications

Ali Zarrinpar

2 joint publications

Thiago Beduschi

2 joint publications

Alexandra D Ladd

2 joint publications

Curtis Warren